96,630 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Two Sigma Investments LP

Two Sigma Investments LP acquired a new position in Grail, Inc. (NASDAQ:GRAL) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 96,630 shares of the company’s stock, valued at approximately $1,725,000. Two Sigma Investments LP owned about 0.29% of Grail at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of GRAL. State of Wyoming purchased a new position in shares of Grail in the fourth quarter worth about $924,000. Tang Capital Management LLC acquired a new stake in Grail in the 4th quarter valued at about $3,570,000. Sessa Capital IM L.P. purchased a new position in Grail in the 4th quarter worth approximately $53,550,000. Shay Capital LLC purchased a new position in Grail in the 4th quarter worth approximately $1,686,000. Finally, Rafferty Asset Management LLC purchased a new stake in shares of Grail in the fourth quarter valued at approximately $998,000.

Grail Stock Performance

GRAL stock opened at $37.50 on Tuesday. Grail, Inc. has a one year low of $12.33 and a one year high of $63.99. The firm has a market cap of $1.35 billion and a PE ratio of -0.61. The firm’s 50 day moving average price is $32.24 and its 200-day moving average price is $28.65.

Grail (NASDAQ:GRAL) last posted its earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, beating analysts’ consensus estimates of ($4.03) by $0.93. The business had revenue of $31.84 million during the quarter, compared to analysts’ expectations of $35.80 million. Equities research analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently commented on GRAL. Canaccord Genuity Group lifted their price objective on Grail from $32.00 to $43.00 and gave the stock a “buy” rating in a research report on Wednesday, May 14th. Morgan Stanley lifted their price target on Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th.

Insider Transactions at Grail

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of the company’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares in the company, valued at $25,862,541.02. This represents a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the sale, the president now directly owns 559,673 shares of the company’s stock, valued at $17,461,797.60. The trade was a 0.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 194,948 shares of company stock worth $6,583,130. 1.85% of the stock is currently owned by insiders.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.